After a challenging 2026 season plagued by numerous injuries, the Toronto Blue Jays are gearing up for an active offseason with an emphasis on strengthening their pitching roster. Among their key concerns is right-hander Dylan Cease, whose debut year with Toronto was cut short in September due to right shoulder inflammation. Although an MRI showed no structural damage and he avoided surgery, Cease experienced a dip in pitching velocity that raised some concerns heading into the offseason.

Cease, who is 30 years old and entering the second year of a lucrative seven-year, $210 million contract, has provided an encouraging update about his recovery. He has emphasized that his offseason will focus heavily on shoulder-specific conditioning and rest, and he does not anticipate needing any invasive medical treatments beyond that. This approach aims to ensure he returns healthy and ready for the 2027 campaign, which is critical for the Blue Jays’ plans given his significant role in their starting rotation.

Throughout the 2026 season, despite his late injury setback, Cease impressed with a strong 2.40 ERA and 239 strikeouts over 169 innings pitched in 29 starts. His performance established him as one of the American League’s top starters before the shoulder inflammation curtailed his season. Reflecting on his late-season decline in velocity, Cease expressed determination to analyze and improve his consistency to finish stronger in the coming year.

In addition to focusing on physical recovery, Cease plans to visit an ashram in southern India as part of his offseason routine before returning to traditional baseball preparation. The Blue Jays are hopeful that with this balanced approach to rehabilitation and rest, Cease will overcome his recent health issues and contribute significantly to their pursuit of postseason success in 2027.